Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,448.40
+17.80 (1.24%)
Jun 19, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 200.7 billion as of June 18, 2026. Its market cap has decreased by -6.83% in one year.
Market Cap
200.70B
Enterprise Value
223.54B
Revenue
31.15B
Ranking
n/a
PE Ratio
32.00
Stock Price
1,448.40
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 200.70B, an increase of 142.67%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 200.70B | -2.14% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 383.86B |
| Gland Pharma | 362.83B |
| Wockhardt | 328.69B |
| Emcure Pharmaceuticals | 327.17B |
| Piramal Pharma | 212.72B |
| Cohance Lifesciences | 162.65B |
| NATCO Pharma | 155.31B |
| Alembic Pharmaceuticals | 146.67B |